Sperm-zona pellucida binding and penetration were assessed on the oocytes that failed to fertilize from couples with >/=3 oocytes treated by standard in-vitro fertilization (IVF). There were four groups: fertilization rate 0% (n = 369), 1-25% (n = 194), 26-50% (n = 81) and 51-95% (n = 100). Of the couples with zero fertilization rate 70% had =5 spermatozoa bound per zona pellucida and 42% had no spermatozoa penetrating the zona pellucida of any oocyte. In contrast, in the 51-95% fertilization rate group, only 17% had = 5 spermatozoa bound per zona pellucida and 6% had no spermatozoa penetrating the zona pellucida. There was a significantly higher frequency of poor sperm morphology (= 5% normal) in couples with zero fertilization rate (36%) than in the fertilization rate group 51-95% (7%). Incubation of oocytes from 68 couples with zero fertilization rate and low sperm-zonae pellucidae binding with fertile donor spermatozoa resulted in normal sperm-zona pellucida binding and most zonae pellucidae being penetrated. In conclusion, defective sperm-zona pellucida interaction was the major cause for low fertilization rates in standard IVF. This was usually because of defects of the spermatozoa rather than defects of the oocytes. Sperm defects likely to cause failure of fertilization should be diagnosed before commencing IVF and the patients directed to intracytoplasmic sperm injection.
Obese fertile men appear to have reduced testicular function. Whether this is cause or effect, i.e. adiposity impairing spermatogenesis or reduced testicular function promoting fat deposition, remains to be determined.
Sperm binding to human ZP is highly selective for double stranded DNA. Sperm with single stranded or denatured DNA bind less or do not bind at all to the ZP, probably because of defects of motility and, more especially, morphology.
More than 75% of motile sperm from fertile men have no ability to bind to the ZP. This finding has important implications for improvement of semen analysis.
Sperm TP detected by IF correlates strongly with sperm-ZP binding capacity but not with the ZP-induced AR. This simple IF assay of TP may be a clinically useful test of sperm function that is predictive of normal sperm ZP-binding capacity.
The spermatozoa of some patients attending for in-vitro fertilization (IVF) fail to penetrate the zona pellucida in vitro. A test has been devised to identify these cases. It is based on the number of spermatozoa penetrating into the zona pellucida, which were counted after removing spermatozoa bound to the zona surface by vigorous aspiration of each oocyte through a narrow gauge (120 microns) glass pipette. The oocytes were collected from 197 patients undergoing IVF treatment with their own gametes; 79 with no oocytes fertilized and 118 with some oocytes fertilized. Sperm motility, morphology and DNA normality (acridine orange stain) were also measured. The relationships between sperm test results and IVF rate were examined by logistic regression. The proportions of penetrated zonae, normal sperm morphology and normal DNA were the most significant factors related to IVF rate in the whole group. Also, in patients with > or = 30 spermatozoa bound per zona pellucida or with normal sperm morphology > or = 30%, the proportion of penetrated zonae and normal DNA were most significant. Oocytes from 42 patients who had zero fertilization and low sperm-zona binding (average, 2.2 spermatozoa/zona pellucida) were re-incubated with normal donor spermatozoa: large numbers of spermatozoa bound (average, 88 spermatozoa/zona pellucida) and each zona was penetrated by at least one spermatozoon. In conclusion, the percentage of zonae penetrated was the variable most significantly correlated with IVF rate. Penetration of the zona was also strongly related to fertilization rates in patients without defects of sperm morphology and sperm-zona binding.(ABSTRACT TRUNCATED AT 250 WORDS)
Clusterin is an abundant protein in the human male reproductive tract which appears to be produced by the testis, epididymis and the seminal vesicles. Using monoclonal antibodies and an amplified immunoperoxidase technique, we have identified two apparently biochemically distinct forms of clusterin on human spermatozoa. Morphologically abnormal spermatozoa have an extensive surface coating of conventional 80 kDa native clusterin, but this form of clusterin is not detectable on normal spermatozoa. Normal spermatozoa, however, contain within the acrosomal cap a different form of clusterin, reactive with an anticlusterin alpha-chain antibody. Agglutinated spermatozoa, most of which are grossly abnormal, were intensely labelled with the antibody against conventional 80 kDa clusterin, suggesting that the 'clustering' properties of this protein may play a role in the aggregation of abnormal spermatozoa. Anticlusterin monoclonal antibodies may be useful for semen analysis. Staining spermatozoa with anticlusterin monoclonal antibodies is a technically simple method which provides a visually obvious means of assessing spermatozoa morphology and acrosome status simultaneously. The current data also suggest that different functions of clusterin in the reproductive tract may be attributed to different molecular forms of the protein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.